Allysurge Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 1 Month
- Last Filing with ROC 31 Mar 2024
About Allysurge Lifescience
Allysurge Lifescience Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 2023 (One year and one month 27 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Vyas, Atman Pandya, Akshay Doshi, and Four other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46909GJ2023PTC147304
- Company No.
147304
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Who are the key members and board of directors at Allysurge Lifescience?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Vyas  | Director | 29-Dec-2023 | Current |
| Atman Pandya | Director | 29-Dec-2023 | Current |
| Akshay Doshi | Director | 29-Dec-2023 | Current |
| Jayraj Chudgar | Director | 29-Dec-2023 | Current |
| Rumit Shah | Director | 29-Dec-2023 | Current |
| Avanishkumar Modi | Director | 29-Dec-2023 | Current |
Financial Performance of Allysurge Lifescience.
Enhance accessibility to Allysurge Lifescience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Allysurge Lifescience?
Unlock access to Allysurge Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Surge Biotech Private LimitedNitin Vyas, Atman Pandya and 1 more are mutual person
Prathna-Unity Pharma LlpAtman Pandya and Akshay Doshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Allysurge Lifescience?
Unlock and access historical data on people associated with Allysurge Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allysurge Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allysurge Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.